Press Release – New York, NY – October 29, 2026 – Sichenzia Ross Ference Carmel LLP announced that it represented Alaunos Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics, in its acquisition of Velaris Therapeutics, Inc., and its concurrent $350 million private placement.
The SRFC team was led by partners Gregory Sichenzia and Marcelle Balcombe, with associate Karina Maas.